ERBB2 and neoplasm: Although through a different mechanism, a further study demonstrated that activation of PI3Kinase or HER2 overexpression—two genetic events commonly observed in breast cancer [78,79]—positively regulate cell motility and tumor metastasis by targeting ΔNp63 [80].